Influenza
"A Randomised Intervention Study to Examine the Effect on Immunisation Coverage of Making Influenza Vaccine Available at No Cost."
Published in Vaccine Weekly, April 14th, 1997
According to the author's abstract of an article published in New Zealand Medical Journal, "Aims: This study aims to assess the effects of two interventions on influenza vaccination coverage: a simple organisational strategy, and making the vaccine available free. Method: Sixteen general practitioners in the Auckland region were randomly selected to participate. Patients over 65 years of these general practitioners were randomly allocated to control, letter of invitation for a flu vaccine, or offer of a free flu vaccine. Administration of a flu vaccine for each person in the study was documented in each general practitioner surgery. Vaccine coverage for each of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-04-14)
More Articles from Vaccine Weekly
- Polio
Biology Favors Global Polio Eradication - Polio
Mass Vaccination Better Than Routine Vaccination - Polio
Planetary Polio Eradication - AIDS Therapies
HIV Replication Increased by Drugs That Prevent Cell Suicide - Argentinian Hemorrhagic Fever
AHF Vaccine Example of What an Orphan Vaccine Means to People - DPT Vaccine
Brazil Recalls DPT Vaccine for the Second Time in a Year - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
